These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 26715462)

  • 1. Impact of NIHR HTA Programme funded research on NICE clinical guidelines: a retrospective cohort.
    Turner S; Bhurke S; Cook A
    Health Res Policy Syst; 2015 Aug; 13():37. PubMed ID: 26297470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Publication rate for funded studies from a major UK health research funder: a cohort study.
    Turner S; Wright D; Maeso R; Cook A; Milne R
    BMJ Open; 2013 May; 3(5):. PubMed ID: 23645914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarifying differences between reviews within evidence ecosystems.
    Gough D; Thomas J; Oliver S
    Syst Rev; 2019 Jul; 8(1):170. PubMed ID: 31307555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Facilitating Factors for Conducting Systematic Evidence Assessments in Academic Clinical Trials.
    McLennan S; Nussbaumer-Streit B; Hemkens LG; Briel M
    JAMA Netw Open; 2021 Nov; 4(11):e2136577. PubMed ID: 34846522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of external evidence for design and Bayesian analysis of clinical trials: a qualitative study of trialists' views.
    Clayton GL; Elliott D; Higgins JPT; Jones HE
    Trials; 2021 Nov; 22(1):789. PubMed ID: 34749778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dissemination rates, non-transparency of trial premature cessation and late registration in child mental health: observational study of registered interventional trials.
    Vrljičak Davidović N; Tokalić R; Burilović E; Pejdo S; Marušić A; Singh S; Franić T
    Eur Child Adolesc Psychiatry; 2020 Jun; 29(6):813-825. PubMed ID: 31486894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesizing existing evidence to design future trials: survey of methodologists from European institutions.
    Nikolakopoulou A; Trelle S; Sutton AJ; Egger M; Salanti G
    Trials; 2019 Jun; 20(1):334. PubMed ID: 31174597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a random effects meta-analysis in the design and analysis of a new clinical trial.
    Jones HE; Ades AE; Sutton AJ; Welton NJ
    Stat Med; 2018 Dec; 37(30):4665-4679. PubMed ID: 30187505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using HTA and guideline development as a tool for research priority setting the NICE way: reducing research waste by identifying the right research to fund.
    Sharma T; Choudhury M; Rejón-Parrilla JC; Jonsson P; Garner S
    BMJ Open; 2018 Mar; 8(3):e019777. PubMed ID: 29523564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involving clinical experts in prioritising topics for health technology assessment: a randomised controlled trial.
    Cook A; Streit E; Davage G
    BMJ Open; 2017 Aug; 7(8):e016104. PubMed ID: 28827250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COMET Handbook: version 1.0.
    Williamson PR; Altman DG; Bagley H; Barnes KL; Blazeby JM; Brookes ST; Clarke M; Gargon E; Gorst S; Harman N; Kirkham JJ; McNair A; Prinsen CAC; Schmitt J; Terwee CB; Young B
    Trials; 2017 Jun; 18(Suppl 3):280. PubMed ID: 28681707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials.
    Clayton GL; Smith IL; Higgins JPT; Mihaylova B; Thorpe B; Cicero R; Lokuge K; Forman JR; Tierney JF; White IR; Sharples LD; Jones HE
    Trials; 2017 May; 18(1):219. PubMed ID: 28506284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All health researchers should begin their training by preparing at least one systematic review.
    Mahtani KR
    J R Soc Med; 2016 Jul; 109(7):264-8. PubMed ID: 27118697
    [No Abstract]   [Full Text] [Related]  

  • 14. Using systematic reviews to inform NIHR HTA trial planning and design: a retrospective cohort.
    Bhurke S; Cook A; Tallant A; Young A; Williams E; Raftery J
    BMC Med Res Methodol; 2015 Dec; 15():108. PubMed ID: 26715462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials.
    Jones AP; Conroy E; Williamson PR; Clarke M; Gamble C
    BMC Med Res Methodol; 2013 Mar; 13():50. PubMed ID: 23530582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The citation of relevant systematic reviews and randomised trials in published reports of trial protocols.
    Pandis N; Fleming PS; Koletsi D; Hopewell S
    Trials; 2016 Dec; 17(1):581. PubMed ID: 27927219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study.
    Blatch-Jones AJ; Pek W; Kirkpatrick E; Ashton-Key M
    BMJ Open; 2018 Sep; 8(9):e022233. PubMed ID: 30257847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive review of statistical methods for analysing patient-reported outcomes (PROs) used as primary outcomes in randomised controlled trials (RCTs) published by the UK's
    Qian Y; Walters SJ; Jacques R; Flight L
    BMJ Open; 2021 Sep; 11(9):e051673. PubMed ID: 34489292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of current practice in the design and assessment of internal pilots in UK NIHR clinical trials.
    Rosala-Hallas A; Gamble C; Blazeby J; Williamson PR
    Trials; 2019 Sep; 20(1):571. PubMed ID: 31533775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.